In a filing, Tarsus Pharmaceuticals Inc revealed its Director LINK WILLIAM J PHD unloaded Company’s shares for reported $0.91 million on Aug 12 ’24. In the deal valued at $26.08 per share,35,000 shares were sold. As a result of this transaction, LINK WILLIAM J PHD now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, FLYING L PARTNERS XI LLC bought 35,000 shares, generating $939,750 in total proceeds.
Before that, Farrow Jeffrey S sold 10,445 shares. Tarsus Pharmaceuticals Inc shares valued at $286,924 were divested by the insider at a price of $27.47 per share. As a result of the transaction, Farrow Jeffrey S now holds 18,136 shares, worth roughly $0.97 million.
Goldman initiated its Tarsus Pharmaceuticals Inc [TARS] rating to a Neutral in a research note published on November 20, 2023; the price target was $19. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in mid July with a ‘”an Outperform”‘ rating. Guggenheim began covering TARS with “Buy” recommendation on May 18, 2023. Barclays started covering the stock on August 01, 2022. It rated TARS as “an Overweight”.
Price Performance Review of TARS
On Tuesday, Tarsus Pharmaceuticals Inc [NASDAQ:TARS] saw its stock jump 2.96% to $53.26. Over the last five days, the stock has gained 5.15%. Tarsus Pharmaceuticals Inc shares have risen nearly 163.01% since the year began. Nevertheless, the stocks have risen 179.58% over the past one year. While a 52-week high of $54.44 was reached on 12/11/24, a 52-week low of $18.44 was recorded on 01/05/24. SMA at 50 days reached $45.14, while 200 days put it at $34.67.
Levels Of Support And Resistance For TARS Stock
The 24-hour chart illustrates a support level at 51.71, which if violated will result in even more drops to 50.17. On the upside, there is a resistance level at 54.17. A further resistance level may holdings at 55.09. The Relative Strength Index (RSI) on the 14-day chart is 64.67, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.08, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 19.70%. Stochastics %K at 69.78% indicates the stock is a holding.
How much short interest is there in Tarsus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Tarsus Pharmaceuticals Inc stocks on 2024-11-29, dropping by -0.98 million shares to a total of 7.18 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 8.16 million shares. There was a decline of -13.61%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 21, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $40 price target.
